Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mechanical aortic valve prostheses are artificial valves constructed from durable materials (including metals and pyrolytic carbon) that are surgically implanted to replace diseased native aortic valves. They are used to treat severe aortic valve stenosis or regurgitation. Mechanical valves function by mimicking the unidirectional blood flow properties of the native valve, offering superior durability compared to tissue (bioprosthetic) valves but requiring lifelong anticoagulation therapy to prevent thromboembolism. Replacement can be done via open-heart surgery or through less invasive methods like transcatheter aortic valve replacement (TAVR). While these devices restore native valve function mechanically, they are not molecular, protein, or receptor targets and do not directly participate in biological signaling or metabolic pathways.
Mechanical obstruction to backward flow; physically replaces damaged/defective aortic valve to restore function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mechanical aortic valve prosthesis.